The launch of the injection faces potential threats, including the Trump administration’s proposed cuts to federal funding ...

The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...

Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be ...

The FDA approved lenacapavir (Yeztugo) as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in at ...

Pfizer’s 7%+ yield is tempting, but rising political, regulatory, and business risks threaten its stability and growth ...

In the face of a changing climate, now is the time for Asean member states to develop a cure for dengue.As we mark Asean Dengue Day tomorrow, it is a timely wake-up call about the growing public ...

For hepatitis B, treatment can suppress the virus and reduce liver inflammation, which helps slow cirrhosis. According to the ...

Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking ...

Researchers from Liverpool School of Tropical Medicine have helped uncover how ticks mount a defense against a deadly virus ...

Doctors compare household painkillers like ibuprofen and acetaminophen, explaining their mechanisms and when each works best ...